Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?

Specific Antigen ◽

External Beam ◽

Patient Age ◽

Patient Âgé

Analysis of the local control in lymph-node staged localized prostate cancer treated by external beam radiotherapy, assessed by digital rectal examination, serum prostate-specific antigen and biopsy

BJU International ◽

10.1046/j.1464-410x.1997.00260.x ◽

1997 ◽

Vol 80 (2) ◽

pp. 247-255 ◽

Cited By ~ 21

Author(s):

G. BORGHEDE ◽

F. ALDENBORG ◽

E. WURZINGER ◽

K.-A. JOHANSSON ◽

H. HEDELIN

Keyword(s):

Prostate Cancer ◽

Lymph Node ◽

Local Control ◽

Specific Antigen ◽

Digital Rectal Examination ◽

External Beam ◽

Serum Prostate Specific Antigen

Kinetics of Prostate Specific Antigen Decline Following Treatment of Localized Prostate Cancer with External Beam Radiotherapy: The Impact of Dose Escalation

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2008.06.1140 ◽

2008 ◽

Vol 72 (1) ◽

pp. S337-S338

Author(s):

D.L. Sherr ◽

J. Poli ◽

R. Mehta ◽

G. Wernicke ◽

D. Nori

Keyword(s):

Prostate Cancer ◽

Dose Escalation ◽

Specific Antigen ◽

External Beam ◽

The Impact ◽

Kinetics Of

External Beam Radiotherapy for Clinically Localized Hormone-Refractory Prostate Cancer: Clinical Significance of Nadir Prostate-Specific Antigen within 12 Months

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2008.06.891 ◽

2008 ◽

Vol 72 (1) ◽

pp. S55-S56

Author(s):

K. Ogawa ◽

K. Nakamura ◽

T. Sasaki ◽

H. Onishi ◽

M. Koizumi ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Significance ◽

Specific Antigen ◽

External Beam ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer

Prostate International ◽

10.1016/j.prnil.2015.12.001 ◽

2016 ◽

Vol 4 (1) ◽

pp. 25-29 ◽

Cited By ~ 2

Author(s):

Jeong Hoon Phak ◽

Hun Jung Kim ◽

Woo Chul Kim

Keyword(s):

Prostate Cancer ◽

Stereotactic Body Radiotherapy ◽

Specific Antigen ◽

External Beam ◽

Conventionally Fractionated

Long-term Results of External Beam Radiotherapy for Prostate Cancer with Prostate-specific Antigen of More Than 50 ng/ml and Without Evidence of Lymph Node or Distant Metastasis

Anticancer Research ◽

10.21873/anticanres.12475 ◽

2018 ◽

Vol 38 (4) ◽

Keyword(s):

Prostate Cancer ◽

Lymph Node ◽

Distant Metastasis ◽

Specific Antigen ◽

Long Term Results ◽

External Beam

Prostate-specific antigen (PSA) rate of decline post external beam radiotherapy predicts prostate cancer death

Radiotherapy and Oncology ◽

10.1016/j.radonc.2013.03.030 ◽

2013 ◽

Vol 107 (2) ◽

pp. 129-133 ◽

Cited By ~ 14

Author(s):

Zumin Shi ◽

Carole B. Pinnock ◽

Stephen Kinsey-Trotman ◽

Martin Borg ◽

Kim L. Moretti ◽

...

Keyword(s):

Prostate Cancer ◽

Specific Antigen ◽

External Beam ◽

Cancer Death ◽

Prostate Cancer Death ◽

Rate Of Decline

Salvage External Beam Radiotherapy for Local Recurrence without Systemic Progression or Prostate Specific Antigen Recurrence of Prostate Cancer after Initial Hormonal Therapy: Is It Possible to Identify Patients Likely to Have Good Treatment Outcomes?

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyf096 ◽

2002 ◽

Vol 32 (11) ◽

pp. 466-471 ◽

Cited By ~ 3

Author(s):

K. Kurokawa

Keyword(s):

Prostate Cancer ◽

Local Recurrence ◽

Treatment Outcomes ◽

Hormonal Therapy ◽

Specific Antigen ◽

Good Treatment ◽

External Beam

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.12566 ◽

2016 ◽

Vol 12 (4) ◽

pp. 388-395 ◽

Cited By ~ 4

Author(s):

Seok Ho Lee ◽

Hun Jung Kim ◽

Woo Chul Kim

Keyword(s):

Prostate Cancer ◽

Stereotactic Body Radiotherapy ◽

Specific Antigen ◽

External Beam ◽

Intermediate Risk ◽

Risk Prostate Cancer ◽

Conventionally Fractionated

Prostate-specific antigen bounce after external beam radiotherapy plus high-dose-rate brachytherapy boost for definitive management of localized prostate cancer

Brachytherapy ◽

10.1016/j.brachy.2009.03.182 ◽

2009 ◽

Vol 8 (2) ◽

pp. 178-179

Author(s):

Anuj V. Peddada ◽

Scott B. Jenings ◽

Patrick O. Faricy ◽

Richard A. Walsh III ◽

Gregory L. Gibbs ◽

...

Keyword(s):

Prostate Cancer ◽

Dose Rate ◽

Specific Antigen ◽

High Dose Rate ◽

High Dose ◽

External Beam ◽

Brachytherapy Boost ◽

Definitive Management

A zero PSA slope in posttreatment prostate-specific antigen supports cure of patients with long-term follow-up after external beam radiotherapy for localized prostate cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(03)00206-2 ◽

2003 ◽

Vol 56 (4) ◽

pp. 1073-1078 ◽

Cited By ~ 19

Author(s):

Robert Takamiya ◽

Vivian Weinberg ◽

C.Dale Young ◽

Howard Sandler ◽

Peter McLaughlin ◽

...

Keyword(s):

Prostate Cancer ◽

Specific Antigen ◽

External Beam ◽

Long Term Follow Up